In combination with the patient’s tumor histology and the loss of immunohistochemical expression of SDHB, this somatic variant is ultimately interpreted as a likely pathogenic somatic variant (confirmed by germline testing) and the potential driver of this presumed sporadic tumor. The gene discussed is SDHB; the disease is neoplasm.